Increased Carotid Intima-Media Thickness and Endothelial Cell-Specific Molecule-1 (Endocan) Levels in Obese Children

Ayşin Nalbantoğlu1, Özgür Kızılca2, Savaş Güzel3

  • 1Faculty of Medicine, Department of Pediatrics, 472605Namık Kemal University, Tekirdağ, Turkey.

Angiology
|March 15, 2021
PubMed

Insights

Childhood obesity is linked to future heart disease. Elevated endocan and carotid intima-media thickness (cIMT) in obese children may signal endothelial damage, suggesting potential biomarkers for early intervention.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health
  • Metabolic Disease Research

Background:

  • Childhood obesity increases the risk of adult cardiovascular and metabolic diseases.
  • Early insulin resistance (IR) can cause endothelial dysfunction and increased carotid intima-media thickness (cIMT) in children.
  • Endothelial cell-specific molecule-1 (endocan) is a potential marker for endothelial damage.

Purpose of the Study:

  • To compare endocan levels in obese children versus healthy controls.
  • To investigate endocan as a potential biomarker for endothelial damage complications in pediatric obesity.
  • To assess the relationship between cIMT, insulin resistance, and endocan levels in obese children.

Main Methods:

  • Study included 80 obese pubertal children and 80 healthy pubertal controls.
  • Evaluated anthropometric measurements, cIMT (via high-resolution ultrasound), endocan levels, and HOMA-IR.
  • Compared these parameters between obese and control groups.

Main Results:

  • Obese children exhibited significantly higher endocan levels, fasting insulin, HOMA-IR, and cIMT compared to controls (P < .001 for all).
  • A significant correlation was found between cIMT and HOMA-IR (β = -1.314, P = .002) in obese children.
  • A significant correlation was observed between cIMT and endocan levels (β = .483, P = .004) in obese children.

Conclusions:

  • Endocan levels are elevated in obese children, suggesting it may serve as a biomarker for endothelial damage.
  • Increased cIMT and HOMA-IR in obese children indicate early cardiovascular and metabolic risks.
  • Noninvasive measurement of cIMT and endocan in obese children can aid early preventive strategies to reduce adult morbidity and mortality.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
896
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
633
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
336
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
87
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
165
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
110